Jane Street »

Gt Biopharma shares owned by Jane Street

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Jane Street

Quarter filed Position value Share count Share price at filing
2025-12-31 $20k 26k 0.79

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Meta Platforms Cl A Call Option (META)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for Jane Street

Top funds holding Gt Biopharma

Scientech Research
SeaCrest Wealth Management
Citadel Advisors
Jane Street
Integrated Wealth Concepts
Geode Capital Management
Coston, McIsaac & Partners
Caitlin John
Wells Fargo & Company
HPM Partners
Am Investment Strategies
Verdence Capital Advisors
Two Sigma Securities
Prospera Financial Services
Hrt Financial

View all funds holding Gt Biopharma